Tonix Pharmaceuticals Holding Corp. (TNXP)

Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

News & Events
: IR Events

IR Events

Archived Events

Sidoti & Company Fall 2019 Investor Conference

Grand Hyatt, New York, NY

Webcast

Ladenburg Thalmann 2019 Healthcare Conference

Sofitel, New York, NY

Webcast

Fall Investor Summit 2019

JW Marriott Essex House, New York, NY

Webcast

2019 NAVREF Conference

San Antonio, Texas

BIO 2019 International Convention

Philadelphia, PA

Webcast

American Society of Clinical Psychopharmacology

Scottsdale, Arizona

Second Chance Digital Impact Recipient Gala

National Harbor, Maryland

2019 Annual Meeting of the Shareholders

The Offices of Lowenstein Sandler LLP at 1251 Avenue of the Americas, New York, New York 10020

Spring Investor Summit 2019

JW Marriott Essex House, New York, NY

Webcast

Sidoti & Company Spring 2019 Conference

Webcast

29th Annual Oppenheimer Healthcare Conference

Westin New York Grand Central, New York, NY

31st Annual ROTH Conference

The Ritz-Carlton, Laguna Niguel, Dana Point, CA

Webcast

21st Annual BIO CEO & Investor Conference

New York Marriott Marquis, New York, NY

Webcast

Biotech Showcase

Hilton San Francisco Union Square (Franciscan A, Ballroom Level)

Webcast

2nd Annual Neuroscience Innovation Forum

Marines’ Memorial Club & Hotel, San Francisco (Room Commandants)

Webcast